Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T13:30:37.874Z.
Calculation as of: 2026-10-06T13:30:37.874Z.
Quote observation: 2026-10-06T13:30:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c84a17f2c5c981e3cafbb97a54cdccede593a8f239875ee545639e7176ba2e68
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Atara Biotherapeutics, Inc.
Market Cap
$84.79M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$85.60M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$84.13M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$88.97M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$87.96M
Operating Cash Flow Yield
30.38%
TTM Avg
24.07%
3Y Avg
48.72%
5Y Avg
43.33%
Market Cap
$88.63M
Operating Cash Flow Yield
N/A
TTM Avg
5.92%
3Y Avg
6.70%
5Y Avg
6.29%
Market Cap
$79.78M
Operating Cash Flow Yield
N/A
TTM Avg
0.15%
3Y Avg
0.15%
5Y Avg
0.15%
Market Cap
$88.21M
Operating Cash Flow Yield
6.68%
TTM Avg
4.42%
3Y Avg
3.83%
5Y Avg
2.85%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Atara Biotherapeutics, Inc. (ATRA) | $84.79M | N/A | N/A | N/A | N/A |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $85.60M | N/A | N/A | N/A | N/A |
| Humacyte, Inc. (HUMA)vs › | $84.17M | N/A | N/A | N/A | N/A |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.13M | N/A | N/A | N/A | N/A |
| Conexeu Sciences Inc. (CNXU)vs › | $88.97M | N/A | N/A | N/A | N/A |
| CareCloud, Inc. (CCLD)vs › | $87.96M | 30.38% | 24.07% | 48.72% | 43.33% |
| Cardiff Oncology, Inc. (CRDF)vs › | $88.63M | N/A | 5.92% | 6.70% | 6.29% |
| Citius Oncology, Inc. (CTOR)vs › | $79.78M | N/A | 0.15% | 0.15% | 0.15% |
| ImmuCell Corporation (ICCC)vs › | $88.21M | 6.68% | 4.42% | 3.83% | 2.85% |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $78.83M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
